While CD38 expression in skin biopsies and blood samples from patients with refractory/relapsed leukemic CTCL has been established previously [15], our study delves into the analysis of existing datasets concerning RNA expression of CD38 in CTCL skin samples. Here, CD38 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.